X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2694) 2694
Book Review (983) 983
Publication (99) 99
Book Chapter (45) 45
Conference Proceeding (15) 15
Magazine Article (5) 5
Book / eBook (2) 2
Dissertation (2) 2
Newsletter (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1751) 1751
humans (1486) 1486
direct oral anticoagulants (999) 999
anticoagulants (960) 960
warfarin (870) 870
dabigatran (826) 826
direct thrombin inhibitor (762) 762
rivaroxaban (718) 718
venous thromboembolism (694) 694
atrial fibrillation (645) 645
hematology (623) 623
administration, oral (583) 583
anticoagulants - therapeutic use (582) 582
peripheral vascular disease (515) 515
male (472) 472
apixaban (431) 431
anticoagulants - administration & dosage (425) 425
female (423) 423
dabigatran etexilate (419) 419
atrial-fibrillation (409) 409
anticoagulants - adverse effects (407) 407
stroke (399) 399
pharmacology & pharmacy (392) 392
thromboembolism (375) 375
cardiac & cardiovascular systems (367) 367
prevention (352) 352
aged (351) 351
thrombin (322) 322
anticoagulation (300) 300
thrombosis (285) 285
middle aged (280) 280
risk factors (279) 279
atrial fibrillation - drug therapy (272) 272
hemorrhage - chemically induced (262) 262
bleeding (258) 258
treatment outcome (256) 256
pharmacokinetics (253) 253
direct oral anticoagulant (245) 245
direct thrombin inhibitors (241) 241
management (236) 236
molecular-weight heparin (235) 235
safety (235) 235
medicine & public health (233) 233
medicine, general & internal (232) 232
stroke prevention (232) 232
stroke - prevention & control (228) 228
factor xa inhibitors (227) 227
blood coagulation - drug effects (226) 226
therapy (214) 214
analysis (213) 213
anticoagulants - pharmacology (211) 211
surgery (210) 210
factor xa inhibitor (208) 208
factor-xa inhibitor (208) 208
deep-vein thrombosis (201) 201
adult (191) 191
atrial fibrillation - complications (188) 188
heparin (187) 187
antithrombotic therapy (186) 186
care and treatment (186) 186
oral anticoagulants (186) 186
aged, 80 and over (183) 183
pharmacodynamics (183) 183
risk (183) 183
patients (180) 180
animals (177) 177
edoxaban (174) 174
nonvalvular atrial-fibrillation (172) 172
drug therapy (170) 170
abridged index medicus (166) 166
prothrombin complex concentrate (166) 166
double-blind (162) 162
cardiology (160) 160
hemorrhage (158) 158
thrombin - antagonists & inhibitors (154) 154
internal medicine (151) 151
ximelagatran (147) 147
beta-alanine - analogs & derivatives (142) 142
vitamin k - antagonists & inhibitors (140) 140
anticoagulants - pharmacokinetics (139) 139
health aspects (135) 135
clinical trials (133) 133
enoxaparin (133) 133
coagulation (131) 131
pulmonary embolism (130) 130
warfarin - therapeutic use (130) 130
reversal (129) 129
cardiac arrhythmia (128) 128
stroke - etiology (128) 128
thromboembolism - prevention & control (128) 128
medical research (126) 126
venous thromboembolism - drug therapy (124) 124
dosage and administration (123) 123
vitamin k antagonists (122) 122
total hip-replacement (121) 121
benzimidazoles - therapeutic use (120) 120
antithrombins - therapeutic use (119) 119
coagulation assays (115) 115
efficacy (115) 115
medicine, experimental (112) 112
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2496) 2496
German (84) 84
French (70) 70
Spanish (49) 49
Japanese (24) 24
Russian (15) 15
Hungarian (7) 7
Czech (4) 4
Italian (4) 4
Polish (4) 4
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 1, pp. 27 - 28
In the pivotal phase III RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial, which involved 18,113 patients with atrial fibrillation... 
dabigatran | rivaroxaban | apixaban | direct oral anticoagulant | vitamin K antagonist | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | EFFICACY | SAFETY | RISK | ATRIAL-FIBRILLATION | WARFARIN | Myocardial infarction | Anticoagulants | Stroke | Mortality | Cardiovascular disease | Infarction | Health risk assessment
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2013, Volume 34, Issue 27, pp. 2094 - 2106
Journal Article
British Journal of Surgery, ISSN 0007-1323, 06/2014, Volume 101, Issue 7, pp. 742 - 749
Journal Article
Gut, ISSN 0017-5749, 03/2016, Volume 65, Issue 3, pp. 374 - 389
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 12, pp. 1333 - 1351
Abstract Direct oral anticoagulants (DOACs) are approved for multiple thromboembolic disorders and provide advantages over existing agents. As with all... 
Cardiovascular | bleeding | management | pharmacology | dabigatran | rivaroxaban | apixaban | direct oral anticoagulant | edoxaban
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 20, pp. 2475 - 2484
Abstract Background Oral anticoagulation (OAC) with warfarin is underused for atrial fibrillation (AF). The availability of direct oral anticoagulants (DOACs)... 
Cardiovascular | Internal Medicine | direct oral anticoagulants | oral anticoagulation | atrial fibrillation | UNITED-STATES | ADHERENT ANTITHROMBOTIC TREATMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | PATTERNS | ASPIRIN | THERAPY | STROKE RISK | UNDERTREATMENT | WARFARIN USE | REGISTRY | INSIGHTS | United States - epidemiology | Stroke - prevention & control | Administration, Oral | Anticoagulants - classification | Atrial Fibrillation - drug therapy | Antithrombins - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Male | Medication Therapy Management - standards | Warfarin - therapeutic use | Medication Therapy Management - organization & administration | Practice Patterns, Physicians' - trends | Practice Patterns, Physicians' - statistics & numerical data | Stroke - etiology | Atrial Fibrillation - epidemiology | Quality Improvement | Female | Registries | Aged | Health Services Accessibility - trends | Needs Assessment | Medical colleges | Warfarin | Atrial fibrillation | Analysis | Anticoagulants (Medicine) | Confidence intervals | Training | Cardiac arrhythmia | Anticoagulants | Fibrillation | Identification methods | Cardiovascular disease | Regression analysis | Drug therapy | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article